Navidea Biopharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €56.63K -87.6% -€13.09M +29.4% -23,117.6% -210 pp -€7.42M -13.1% -13,093.6% -110 pp
    €458.48K -41.9% -€10.12M +10.3% -2,207.1% -10 pp -€8.53M +27.4% -1,860.5% -10 pp
    €789.28K +3,337.6% -€9.18M -2.8% -1,162.8% +400 pp -€6.69M -16.5% -848.1% +340 pp
    €22.96K -91.7% -€9.44M -32.1% -41,120.9% -360 pp -€8.02M -315.2% -34,931.4% -360 pp
    €278.20K -82.2% -€13.91M -121.5% -5,000.1% -91 pp €3.73M -92.7% 1,340.0% -19 pp
    €1.56M -91.8% €64.65M -623.8% 4,139.7% +42 pp €50.99M +1,561.2% 3,265.4% +32 pp
    €18.95M +65.8% -€12.34M -48.1% -65.1% +1.4 pp €3.07M -118.7% 16.2% +1.6 pp
    €11.43M +111.1% -€23.78M -22.9% -208.0% +3.6 pp -€16.40M -31.9% -143.5% +3.0 pp
    €5.41M +455.0% -€30.82M -16.3% -569.4% +32 pp -€24.10M -18.6% -445.2% +26 pp
    €975.27K +1,335.9% -€36.83M +46.4% -3,776.6% +330 pp -€29.60M +47.6% -3,035.4% +260 pp
    €67.92K -86.8% -€25.15M -619.5% -37,030.7% -380 pp -€20.06M +47.4% -29,530.2% -270 pp
    €515.59K -94.4% €4.84M -111.2% 939.1% +14 pp -€13.61M +230.6% -2,638.9% -26 pp
    €9.23M +12.4% -€43.10M +26.2% -466.9% -0.51 pp -€4.12M +263.0% -44.6% -0.31 pp
    €8.21M +20.7% -€34.16M +666.6% -416.1% -3.5 pp -€1.13M -54.5% -13.8% +0.23 pp
    €6.80M +10.7% -€4.46M +1.5% -65.5% +0.059 pp -€2.49M +137.3% -36.6% -0.20 pp
    €6.15M +17.7% -€4.39M +7.3% -71.4% +0.069 pp -€1.05M -64.0% -17.1% +0.39 pp
    €5.22M +2.2% -€4.09M -3.8% -78.4% +0.049 pp -€2.92M +16.8% -55.9% -0.070 pp
    €5.11M -0.6% -€4.25M +39.2% -83.3% -0.24 pp -€2.50M +292.6% -48.9% -0.37 pp
    €5.13M -8.6% -€3.05M +96.8% -59.5% -0.32 pp -€636.11K -57.6% -12.4% +0.14 pp
    €5.62M +32.3% -€1.55M -39.3% -27.6% +0.33 pp -€1.50M -36.8% -26.7% +0.29 pp
    €4.24M -35.1% -€2.56M -19,920.3% -60.2% -0.60 pp -€2.37M +1,243.2% -55.9% -0.53 pp
    €6.54M -21.9% €12.90K -99.2% 0.2% -0.19 pp -€176.81K -111.1% -2.7% -0.22 pp
    €8.38M +2.8% €1.59M -144.1% 18.9% +0.63 pp €1.59M -10.2% 18.9% -0.027 pp
    €8.15M +61.9% -€3.60M -85.1% -44.2% +4.4 pp €1.77M -111.5% 21.7% +3.3 pp
    €5.03M +13.7% -€24.18M +20.6% -480.6% -0.27 pp -€15.34M +5.7% -304.9% +0.23 pp
    €4.42M +337.8% -€20.05M +10.9% -453.3% +13 pp -€14.50M +55.7% -327.9% +5.9 pp
    €1.01M +17.1% -€18.09M +94.2% -1,790.4% -7.1 pp -€9.31M +38.4% -922.0% -1.4 pp
    €862.59K +11.1% -€9.32M +0.0% -1,080.0% +1.2 pp -€6.73M +0.0% -780.0% +0.87 pp
    €776.33K +800.0% -€9.32M +35.0% -1,200.0% +68 pp -€6.73M +11.4% -866.7% +61 pp
    €86.26K +0.0% -€6.90M +207.7% -8,000.0% -54 pp -€6.04M +204.3% -7,000.0% -47 pp
    €86.26K -€2.24M -2,600.0% -€1.98M -2,300.0%

    Notifications